Intermountain Healthcare

Largest Health Care Genomics Study Expanding Growth and Accessibility with New Collection Sites


Salt Lake City, UT -- (ReleaseWire) -- 10/21/2020 --When the HerediGene: Population Study began, Intermountain research teams collected blood samples from a collection site in Murray and another in St. George, Utah. Now, there are more collection sites opening throughout the state at Intermountain Healthcare hospitals and clinics along the I-15 corridor.

"We have participation sites opening all over Intermountain Healthcare," said Lincoln Nadauld, MD, PhD, Intermountain's chief of precision health and principal investigator of the HerediGene: Population Study. "These are walk in clinics. These are outpatient phlebotomy labs. There are many opportunities at different locations for patients to come and sign up and participate in HerediGene."

Intermountain invites everyone to consider participating in this study. Its focus is to find newconnections between genetics and human disease by consenting, collecting and performing a whole genome analysis on 500,000 participants before the end of 2023.

"The result will be discoveries that will dramatically impact and radically improve the delivery of healthcare," Dr. Nadauld said. "For those who participate, we'll positively affect their health care immediately and dramatically improve the health care for their children and grandchildren."

To see the where the latest collection sites have opened, anyone can go online to

About Intermountain Healthcare
Intermountain Healthcare is a not-for-profit system of 24 hospitals, 215 clinics, a Medical Group with 2,500 employed physicians and advanced practice clinicians, a health insurance company called SelectHealth, and other health services in Idaho, Utah, and Nevada. Intermountain is widely recognized as a leader in transforming healthcare by using evidence-based best practices to consistently deliver high-quality outcomes and sustainable costs. For more information, see